Search - tctmd.com

Displaying 81 - 100 of 704

Sort: Relevancy | Date

News Conference News EHRA 2024

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

Todd Neale

April 10, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News ACC 2024

EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2

Shelley Wood

April 07, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Daily News

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Yael L. Maxwell

March 21, 2024

News Daily News

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

Caitlin E. Cox

March 01, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Caitlin E. Cox

February 09, 2024

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

Todd Neale

January 11, 2024

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Caitlin E. Cox

December 07, 2023

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News AHA 2023

Coincidental Nonischemic Cardiomyopathy Impacts Prognosis in CAD

Todd Neale

November 09, 2023

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

Presentation TCT 2023

TCT 63: Cost-Effectiveness of Fractional Flow Reserve in Patients with Acute Myocardial Infarction and Multivessel Disease: Prespecified Analysis of FRAME-AMI Trial

Presenter: Seung Hun Lee

October 26, 2023

Advertisement

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2

What’s Going to Be Hot at ACC 2024

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

Top Coronary Artery Disease News of 2023

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Coincidental Nonischemic Cardiomyopathy Impacts Prognosis in CAD

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

TCT 63: Cost-Effectiveness of Fractional Flow Reserve in Patients with Acute Myocardial Infarction and Multivessel Disease: Prespecified Analysis of FRAME-AMI Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content